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To the Editor,
We read with interest the article by De Schepper et al. [1] on
the evaluation of quantitative ultrasound bone sonometry (QUS)
at the distal left radius as a selective population pre-screening
method to maximize the cost effectiveness and to limit the
exposure to dual X-ray absorptiometry (DXA) in young cystic
fibrosis (CF) patients.
Parallel to the publication of this study, our group has recently
published [2] QUS findings in 35 Spanish children and young
adults with CF within a population-based study on bone turnover
markers. The mean age was 11.8±5.5 years, and the participants
were recruited using methodology similar to that of De Schepper
et al., excluding those who were being treated with bone active
medication other than corticoids or routine vitamin D supple-
mentation. We measured bone properties using phalangeal QUS
and did not find differences between well-nourished CF patients
and weight-, height- and age-matched control cohort of healthy
subjects. Measurements in the CF group were inside the reference
ranges that we have previously described for phalangeal QUS in
the Spanish pediatric population [3]. Therefore, we agree with
Shepper et al. that QUS can effectively screen out CF patients
with normal bone mass.
According to the official position of the International Society
for Clinical Densitometry (ISCD) 2007, the diagnosis of bone
disorders in pediatric patients still relies on a clinically significant
fracture history that includes the number, type and site of
fractures. Thus, the effectiveness of a method is dependent on its
reliability in discriminating patients with and without fractures.
QUS methods are safe, rapid, easy to use, radiation free and cost
effective, making them attractive for use in pediatric populations.
Phalangeal QUS assesses the skeletal condition using two
parameters: AD-SoS (ultrasound wave speed), which mostly
reflects bone density, and elasticity and BTT (ultrasound signal
transmission time), which is related to cortical thickness and
discriminates between different patterns of bone diseases
independent of bone density. In a recent study by Mussa et al.
[4] that involved 1719 pediatric patients with bone disorders1569-1993/$ -see front matter © 2012 European Cystic Fibrosis Society. Published
http://dx.doi.org/10.1016/j.jcf.2012.10.006(including 69 with CF with a mean age of 13.8±4.3 years),
phalangeal QUS identified fractured pediatric patients with bone
disorders, reflected the severity of the causative trauma and
showed a high discrimination power for fragility fractures. We
agree with De Schepper et al. that DXA cannot replace QUS for
CF-related bone disease, but the investigation of pediatric
measurement has revealed differences. DXA and calcaneal
QUS discriminated patients with positive fracture history [5];
however, this was not the case for radial QUS and metacarpal
index, most likely because they primarily measure cortical bone.
We believe that the phalanges are more informative for detecting
bone-related diseases in diseased children because they comprise
both cortical and cancellous bones.
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